Carmine Vincifora, MD
Pain Medicine · Longview, TXNPI 1265752315
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Boston Scientific at 39.5% of the total. Reporting peaked in 2022 at $3,201 and has fallen 95.1% since, to $156 in 2025.
Across 227 payments — averaging $39.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Abbott$2K
- Relievant Medsystems, Inc.$856
- MML US, Inc.$684
- Painteq LLC$677
- Medtronic$475
- plus $805 from 9 others
What the payments were for
- Travel & lodging$3,79942%
- Food & beverage$4,13146%
- Education$1,08012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 45 | $3,560 |
| Abbott | 129 | $1,953 |
| Relievant Medsystems, Inc. | 9 | $856 |
| MML US, Inc. | 4 | $684 |
| Painteq LLC | 3 | $677 |
| Medtronic(2 entities) | 16 | $475 |
| Nevro Corp. | 11 | $430 |
| Vertos Medical, Inc. | 2 | $233 |
| Stryker | 2 | $30 |
| Nalu Medical, Inc. | 1 | $29 |
| Pylant Medical | 1 | $21 |
| Vertex | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Vertiflex, Inc. | 1 | $15 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,742
- Superion Indirect Decompression System$2,407
- ReActiv8$622
- PAINTEQ$597
- KYPHON Balloon Kyphoplasty$258
- mild Device Kit$233
- PROCLAIM$128
- Omnia$117
- Proclaim Family of SCS IPGs$109
How this compares
$9,011 in reported general payments places this provider in the 75th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 14 | $9,196 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 264 | $8,011 |
| MovantikNaloxegol Oxalate | 11 | $3,998 |
| Fentanyl | 43 | $3,280 |
| Gabapentin | 162 | $1,767 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 87 | $1,371 |
| Oxycodone Hcl | 54 | $963 |
| Pregabalin | 47 | $554 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 47 | $483 |
| Tramadol Hcl | 59 | $468 |
| Methadone Hcl | 37 | $466 |
| Diclofenac Sodium | 14 | $279 |
| Duloxetine Hcl | 28 | $265 |
| Methocarbamol | 33 | $196 |
| Cephalexin | 37 | $145 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Longview
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Anthony BergRockwall$165K
- Puneet SayalCorpus Christi$153K
- Eduardo GarciaWebster$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.